Schroder Investment Management Group Gritstone Bio, Inc. Transaction History

Schroder Investment Management Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.63 - $8.09 $264,767 - $814,436	-100,672 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$7.07 - $11.61 $391,925 - $643,600	-55,435 Reduced 35.51%	100,672 $903,000
Q3 2019 Nov 12, 2019	BUY	$8.45 - $12.28 $304,749 - $442,878	36,065 Added 30.04%	156,107 $1.32 Million
Q2 2019 Aug 08, 2019	BUY	$9.2 - $15.7 $1.1 Million - $1.88 Million	120,042 New	120,042 $1.34 Million

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.